Business Sentiment Survey

Shoppers are silhouetted as they stand near a sign advertising a sale at a shopping mall in Mumbai February 11, 2013. REUTERS/Vivek Prakash/Files

Asian businesses optimistic; sentiment in India falls

Asia's top companies have become more optimistic about their business outlook with the retail and shipping industries rebounding sharply in the second quarter of 2013, the latest Thomson Reuters/INSEAD Asia Business Sentiment Survey shows.  Full Article 

  • Most Popular
  • Most Shared

REUTERS SHOWCASE

EU Fines Ranbaxy

EU Fines Ranbaxy

EU fines Ranbaxy, others for blocking cheaper drugs.  Full Article 

Asian Stocks Outlook

Asian Stocks Outlook

Asian stocks to lead the way to year's end, Fed seen pulling back - Reuters Poll.  Full Article 

Trade Reforms

Trade Reforms

U.S. groups form alliance to push for Indian trade reforms.  Full Article 

Options Before Fed

Options Before Fed

Fed seen keeping options open on pace of bond buying.  Full Article 

Financing Trouble

Financing Trouble

U.S. court lets stand Ex-Im Bank loan for Air India.  Full Article 

Advertising Milestone

Advertising Milestone

Exclusive - Facebook reaches 1 million active advertisers.  Full Article 

Buy, Sell or Hold?

Buy, Sell or Hold?

Confused while buying stocks? Get buy, sell or hold recommendations from VantageTrade.  Full Coverage 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage 

MARKET EYE-Cipla gains on partner's contract win

Related Topics

Stocks

   

Picture Gallery

Rahul Gandhi

Rahul Gandhi

The Congress lawmaker and scion of the Nehru-Gandhi dynasty turns 43 on Wednesday.  Slideshow 

» Click here for more slideshows

Fri Nov 30, 2012 10:45am IST 

* Shares in drugmaker Cipla rise 1.4 percent after
Cipla Medpro won a share in South Africa's $667 million
contract, as it supplies the bulk of Cipla Medpro's drugs.
* Dealers say the company may garner revenues of $30-40 million
from Cipla Medpro's contract.
* South Africa on Thursday awarded a $667 million contract to
supply life-prolonging HIV medicine to 12 international and
domestic firms, including Cipla Medpro, to deal with its biggest
health problem. 
* Cipla also plans to offer $215 million for a majority stake in
South Africa's Cipla Medpro to strengthen its presence in
Africa's fast-growing market for cheap, generic versions of
branded drugs. 

 (abhishek.vishnoi@thomsonreuters.com /;
abhishek.vishnoi.reuters.com@reuters.net)
India Markets
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.